東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Rare diseases epidemiology = update ...

Posada de la Paz, Manuel.

FindBook

Google Book

Amazon

博客來

Rare diseases epidemiology = update and overview /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Rare diseases epidemiology/ edited by Manuel Posada de la Paz, Domenica Taruscio, Stephen C. Groft.
其他題名:	update and overview /
其他作者:	Posada de la Paz, Manuel.
出版者:	Cham :Springer International Publishing : : 2017.,
面頁冊數:	xxxvi, 667 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	Rare diseases - Epidemiology. -
電子資源:	http://dx.doi.org/10.1007/978-3-319-67144-4
ISBN:	9783319671444

Rare diseases epidemiology = update and overview /
Rare diseases epidemiologyupdate and overview /[electronic resource] :edited by Manuel Posada de la Paz, Domenica Taruscio, Stephen C. Groft. - 2nd ed. - Cham :Springer International Publishing :2017. - xxxvi, 667 p. :ill., digital ;24 cm. - Advances in experimental medicine and biology,v.10310065-2598 ;. - Advances in experimental medicine and biology ;v.1031..

This second edition of the book about Rare Diseases Epidemiology aims to highlight the progress of rare diseases research and related activities since the first volume published. As with the previous book, this update provides a comprehensive list of issues and adds new authors who are leaders in their different areas of expertise related to rare diseases at national and international levels. Rare diseases and orphan drugs are challenges for patients and families but also for physicians, researchers, and policy-makers in both the public and private sectors. This book aims to help all of them to address topics like health care policies, societal issues and clinical and experimental research. Readers will discover methods and procedures to address a variety of questions like cases of undiagnosed rare diseases, patient registries and biobanks, health care and public health approach to rare diseases, orphan drugs and new therapies, cost-effectiveness analyses, prevention, clinical and epidemiology of individual and groups of related rare diseases, novel advances in study design and data analyses, national and international policies and social issues. Within each one of these general issues, advances, new challenges and opportunities to address significant health care issues are described across thirty-two chapters. Editors and all authors providing chapters include globally recognized experts in different areas of rare diseases, including epidemiology, public health, health economics and pharmacology, statistics, and basic, clinical and translational research. People engaged in policy formulation decisions on rare diseases as well as patient representatives relate their own point of view about social constraints they live under on a daily basis. Renowned research investigators, highly-skilled clinicians, and recognized patient leaders are included as contributing authors to this new book about rare diseases. In fact, two of the editors are the current President and President Elect of the International Conference on Rare Diseases and Orphan Drugs and the third one is a board member of this society. The book has been written for all stakeholders but mainly for those involved in the many issues related to rare diseases. They can discover new ways for dealing with important matters related to the prevention, diagnosis, natural history, treatments, and research of rare diseases and the development of orphan products.

ISBN: 9783319671444

Standard No.: 10.1007/978-3-319-67144-4doiSubjects--Topical Terms:

3270656
Rare diseases
--Epidemiology.

LC Class. No.: RC48.8 / .R37 2017

Dewey Class. No.: 616

Rare diseases epidemiology = update and overview /
LDR:03535nmm a2200325 a 4500 001 2112715
003 DE-He213
005 20171206104342.0
006 m d
007 cr nn 008maaau
008 180719s2017 gw s 0 eng d
020 $a 9783319671444 $q (electronic bk.)
020 $a 9783319671420 $q (paper)
024 7 $a 10.1007/978-3-319-67144-4 $2 doi
035 $a 978-3-319-67144-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC48.8 $b .R37 2017
072 7 $a MBN $2 bicssc
072 7 $a MED076000 $2 bisacsh
082 0 4 $a 616 $2 23
090 $a RC48.8 $b .R221 2017
245 0 0 $a Rare diseases epidemiology $h [electronic resource] : $b update and overview / $c edited by Manuel Posada de la Paz, Domenica Taruscio, Stephen C. Groft.
250 $a 2nd ed.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2017.
300 $a xxxvi, 667 p. : $b ill., digital ; $c 24 cm.
490 1 $a Advances in experimental medicine and biology, $x 0065-2598 ; $v v.1031
520 $a This second edition of the book about Rare Diseases Epidemiology aims to highlight the progress of rare diseases research and related activities since the first volume published. As with the previous book, this update provides a comprehensive list of issues and adds new authors who are leaders in their different areas of expertise related to rare diseases at national and international levels. Rare diseases and orphan drugs are challenges for patients and families but also for physicians, researchers, and policy-makers in both the public and private sectors. This book aims to help all of them to address topics like health care policies, societal issues and clinical and experimental research. Readers will discover methods and procedures to address a variety of questions like cases of undiagnosed rare diseases, patient registries and biobanks, health care and public health approach to rare diseases, orphan drugs and new therapies, cost-effectiveness analyses, prevention, clinical and epidemiology of individual and groups of related rare diseases, novel advances in study design and data analyses, national and international policies and social issues. Within each one of these general issues, advances, new challenges and opportunities to address significant health care issues are described across thirty-two chapters. Editors and all authors providing chapters include globally recognized experts in different areas of rare diseases, including epidemiology, public health, health economics and pharmacology, statistics, and basic, clinical and translational research. People engaged in policy formulation decisions on rare diseases as well as patient representatives relate their own point of view about social constraints they live under on a daily basis. Renowned research investigators, highly-skilled clinicians, and recognized patient leaders are included as contributing authors to this new book about rare diseases. In fact, two of the editors are the current President and President Elect of the International Conference on Rare Diseases and Orphan Drugs and the third one is a board member of this society. The book has been written for all stakeholders but mainly for those involved in the many issues related to rare diseases. They can discover new ways for dealing with important matters related to the prevention, diagnosis, natural history, treatments, and research of rare diseases and the development of orphan products.
650 0 $a Rare diseases $x Epidemiology. $3 3270656
650 1 4 $a Medicine & Public Health. $3 890906
650 2 4 $a Health Promotion and Disease Prevention. $3 894308
650 2 4 $a Human Genetics. $3 891169
650 2 4 $a Epidemiology. $3 568544
700 1 $a Posada de la Paz, Manuel. $3 1243987
700 1 $a Taruscio, Domenica. $3 3270654
700 1 $a Groft, Stephen C. $3 1243986
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a Advances in experimental medicine and biology ; $v v.1031. $3 3270655
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-67144-4
950 $a Biomedical and Life Sciences (Springer-11642)